Technical Analysis for ACST - Acasti Pharma, Inc.
|Grade||Last Price||% Change||Price Change|
ACST closed up 0.76 percent on Wednesday, October 18, 2017, on 9 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline.
|Weak or Absent||Up||Up||Down|
|See historical ACST trend table...|
|Date||Alert Name||Type||% Chg|
|Oct 18||Crossed Above 50 DMA||Bullish||0.00%|
|Oct 18||Narrow Range Bar||Range Contraction||0.00%|
|Oct 17||Fell Below 50 DMA||Bearish||0.76%|
|Oct 17||MACD Bearish Signal Line Cross||Bearish||0.76%|
|Oct 17||180 Bearish Setup||Bearish Swing Setup||0.76%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more ACST news...
|52 Week High||2.46|
|52 Week Low||1.11|
|200-Day Moving Average||1.2974|
|50-Day Moving Average||1.321|
|20-Day Moving Average||1.3433|
|10-Day Moving Average||1.3419|
|Average True Range||0.0462|
|Chandelier Exit (Long, 3 ATRs )||1.3114|
|Chandelier Exit (Short, 3 ATRs )||1.4186|
|Upper Bollinger Band||1.3944|
|Lower Bollinger Band||1.2922|
|Percent B (%b)||0.37|
|MACD Signal Line||0.0081|
|Market Cap||19.56 Million|
|Num Shares||14.7 Million|
|Price-to-Earnings (P/E) Ratio||-1.73|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.36|
|Resistance 3 (R3)||1.36||1.35||1.36|
|Resistance 2 (R2)||1.35||1.34||1.35||1.35|
|Resistance 1 (R1)||1.34||1.34||1.35||1.34||1.35|
|Support 1 (S1)||1.32||1.32||1.33||1.32||1.31|
|Support 2 (S2)||1.31||1.32||1.31||1.31|
|Support 3 (S3)||1.30||1.31||1.31|
|Support 4 (S4)||1.30|